A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma
Martin H. Voss, Rupal S. Bhatt, Nicholas J. Vogelzang, Mayer N. Fishman, Robert Alter, Brian I. Rini, J. Thaddeus Beck, Monika Joshi, Ralph J. Hauke, Michael B. Atkins, Earle Burgess, Theodore F. Logan, David Shaffer, Rahul Parikh, Nauman Moazzam, Xiaosha Zhang, Chad Glasser, Matthew L. Sherman, Elizabeth R. Plimack
Research output: Contribution to journal › Article › peer-review
21Scopus
citations
Fingerprint
Dive into the research topics of 'A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma'. Together they form a unique fingerprint.